Home › Funds › Norges Bank Investment Management › MDGL
Norges Bank Investment Management position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)213.89K sh
Reported value held$114.85M
Portfolio Weight0.01%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 116.30K | $33.76M | New |
| Q4 2023 | 145.59K | $33.69M | Add |
| Q2 2024 | 116.03K | $32.51M | Reduce |
| Q4 2024 | 115.09K | $35.51M | Reduce |
| Q2 2025 | 176.47K | $53.41M | Add |
| Q4 2025 | 196.39K | $114.37M | Add |
| Q2 2026 | 213.89K | $114.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Invesco Ltd 301.44K sh · $161.86M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026